Clinical Trial Update: Reactogenicity, Safety and Immunogenicity of a TB/FLU-01L Tuberculosis Vaccine [Phase 1]

View source ↗

Summary

This document reports the results of a Phase 1 trial evaluating the reactogenicity, safety, and immunogenicity of the TB/FLU-01L tuberculosis vaccine. The study…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Tuberculosis

Drugs mentioned

• TB/FLU-01L Tuberculosis Vaccine (TB/FLU-01L vaccine)

Snippet

Sponsor: Research Institute for Biological Safety Problems | Conditions: Tuberculosis | Phase 1 | Status: COMPLETED